CJC-1295 DAC is a synthetic compound that is an analogue of the Growth Hormone-Releasing Hormone (GHRH) somatoliberin, both after single and repeated administration. It also increases insulin-like growth factor 1 (IGF-1) levels in blood plasma.
DAC™ in this case it exhibits an additive grouping effect that extends the half-life of CJC-1295 in the blood plasma.
Due to its presence in the structure, the agent promotes increased production and secretion of GH up to 14 days, which is in parallel with the maintenance of the compound in the body in a concentration that can be studied.
A significant benefit of this compound is that it has been used in complex scientific studies on animal models. This makes it possible to estimate the most effective dosage, potential side effects and dangers of its use.
This peptide was described for the first time in 2006, and the Canadian company ConjuChem Biotechnologies is recognised as its creator.
Composition of the preparation CJC-1295 DAC 5mg
Preparation CJC-1295 DAC 5mg contains 5mg of the active substance. The preparation is characterized by a high degree of chemical purity and is subject to quality control.
CJC-1295 DAC 5mg it is a chemical intended for research purposes only.
In order to ensure the highest quality of the product, laboratory tests for concentration and purity, which can be found in the Studies tab, are carried out for each batch of the product.
The product is available for sale to individuals and research institutions, laboratories, universities or chemical study circles intended to conduct research.
The product is not a food product or a dietary supplement, and is not suitable for human consumption.
If you feel unwell or experience side effects from contact with the substance, consult your doctor.
Special storage conditions
Keep the undiluted vial of lyophilised powder in a cool, dry and dark place. After reconstitution, the substance should be stored at a temperature between 2 and 8 °C.
All of the above properties have been observed in laboratory studies not conducted on humans, and are intended for informational purposes only. None of the information contained in the descriptions is approved by the Chief Sanitary inspectorate of Poland (GIS), the Chief Pharmaceutical Inspectorate of Poland (GIF) or the European Food Safety Authority (EFSA). This product is not a medicine, food or dietary supplement and is not suitable for human consumption. The product is classified as a chemical reagent/reference material authorised for use in the European Union and may only be used for scientific research. Other information about the product is contained in the safety data sheet, which we make available for inspection. The products are only available to institutions or individuals that are associated with research or laboratory activities.